Lexicon Pharmaceuticals Inc (LXRX)

Jan 01, 2026

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat

Jan 01, 2026

Dec 27, 2025

Aug Update: Will Lexicon Pharmaceuticals Inc stock outperform Dow Jones index2025 Big Picture & Low Drawdown Trading Strategies - moha.gov.vn

Dec 27, 2025

Dec 26, 2025

Lexicon Pharmaceuticals (NASDAQ:LXRX) Is Using Debt Safely - 富途牛牛

Dec 26, 2025

Dec 25, 2025

Profit Recap: Can Lexicon Pharmaceuticals Inc stock continue upward trendRisk Management & Free Daily Entry Point Trade Alerts - moha.gov.vn

Dec 25, 2025

Dec 24, 2025

Lexicon Pharmaceuticals (NASDAQ:LXRX) Shares Cross Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat

Dec 24, 2025

Dec 23, 2025

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) stock most popular amongst private equity firms who own 48%, while individual investors hold 27% - Yahoo Finance

Dec 23, 2025

Dec 22, 2025

Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN), Lexicon Pharmaceuticals (LXRX) and Pfizer (PFE) - The Globe and Mail

Dec 22, 2025

Dec 22, 2025

Lexicon Pharmaceuticals accelerates partnerships with patients on innovative therapies - Traders Union

Dec 22, 2025

Dec 20, 2025

How currency fluctuations impact Lexicon Pharmaceuticals Inc. stockWeekly Profit Summary & Stock Portfolio Risk Control - Улправда

Dec 20, 2025

Dec 20, 2025

FOMO Trade: Can Lexicon Pharmaceuticals Inc. stock continue upward trendQuarterly Investment Review & AI Powered Buy and Sell Recommendations - Улправда

Dec 20, 2025

Dec 20, 2025

Patterns Watch: Will Lexicon Pharmaceuticals Inc. stock outperform Dow Jones index2025 Fundamental Recap & Smart Allocation Stock Reports - moha.gov.vn

Dec 20, 2025

Dec 20, 2025

Investment Report: Why Lexicon Pharmaceuticals Inc. stock appeals to dividend seekers2025 Buyback Activity & Risk Managed Trade Strategies - Улправда

Dec 20, 2025

Dec 20, 2025

Aug Catalysts: Is Lexicon Pharmaceuticals Inc. stock resilient to inflation2025 Dividend Review & Advanced Technical Analysis Signals - Улправда

Dec 20, 2025

Dec 20, 2025

AI Stocks: Can Lexicon Pharmaceuticals Inc. stock beat market expectations this quarterVolume Spike & Real-Time Stock Movement Alerts - Улправда

Dec 20, 2025

Dec 19, 2025

Why Lexicon Pharmaceuticals Inc. stock is a must watch in 2025July 2025 Patterns & Entry Point Strategy Guides - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Can Lexicon Pharmaceuticals Inc. stock weather global recessionMarket Sentiment Report & Comprehensive Market Scan Reports - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Can Lexicon Pharmaceuticals Inc. stock rebound after recent weaknessWeekly Profit Recap & Free Fast Entry Momentum Trade Alerts - DonanımHaber

Dec 19, 2025

Dec 19, 2025

How Lexicon Pharmaceuticals Inc. stock benefits from tech adoptionJuly 2025 Final Week & AI Optimized Trade Strategies - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Surprises Report: Will Lexicon Pharmaceuticals Inc. stock deliver long term returnsEarnings Growth Report & Daily Oversold Stock Bounce Ideas - Улправда

Dec 19, 2025

Dec 18, 2025

Is Lexicon Pharmaceuticals Inc. stock resilient to inflation2025 Sector Review & Capital Efficiency Focused Strategies - Улправда

Dec 18, 2025

Dec 18, 2025

Is Lexicon Pharmaceuticals Inc. stock in correction or buying zone2025 Key Highlights & Real-Time Price Movement Reports - Улправда

Dec 18, 2025

Dec 18, 2025

Lexicon Pharmaceuticals, Inc.(NasdaqCM:LXRX) dropped from NASDAQ Biotechnology Index - marketscreener.com

Dec 18, 2025

Dec 18, 2025

Can Lexicon Pharmaceuticals Inc. stock continue upward trend2025 Key Highlights & High Win Rate Trade Alerts - Улправда

Dec 18, 2025

Dec 18, 2025

Why Lexicon Pharmaceuticals Inc. stock appeals to dividend seekersJuly 2025 Big Picture & Detailed Earnings Play Strategies - Улправда

Dec 18, 2025

Dec 18, 2025

Here's Why Lexicon Pharmaceuticals (NASDAQ:LXRX) Can Manage Its Debt Despite Losing Money - simplywall.st

Dec 18, 2025

Dec 16, 2025

Short Covering: How risky is Lexicon Pharmaceuticals Inc stock now2025 Fundamental Recap & Community Verified Trade Alerts - moha.gov.vn

Dec 16, 2025

Dec 16, 2025

Lexicon Pharmaceuticals (NASDAQ:LXRX) Shares Cross Above 200 Day Moving AverageTime to Sell? - MarketBeat

Dec 16, 2025

Dec 10, 2025

Lexicon Pharmaceuticals to advance obesity treatment with new ACSL5 inhibitor data - Traders Union

Dec 10, 2025

Dec 10, 2025

Novo Nordisk (NVO) Collaborates with Lexicon on Obesity Treatmen - GuruFocus

Dec 10, 2025

Dec 10, 2025

Lexicon Pharmaceuticals Publishes Preclinical Data Supporting ACSL5 as Target for Obesity Treatment - Quiver Quantitative

Dec 10, 2025

Dec 10, 2025

Lexicon publishes preclinical data supporting LX9851 obesity treatment - StreetInsider

Dec 10, 2025

Dec 10, 2025

Lexicon Pharmaceuticals Announces Publication of Preclinical Data in the Journal of the Endocrine Society on Acyl-CoA Synthetase 5 (ACSL5) Reinforcing the Scientific Rationale for LX9851 - Yahoo Finance

Dec 10, 2025

Dec 10, 2025

Lexicon publishes preclinical data validating ACSL5 as obesity target - Investing.com

Dec 10, 2025

Dec 07, 2025

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Receives Average Rating of "Hold" from Brokerages - MarketBeat

Dec 07, 2025

Dec 05, 2025

Clinical data on effect of sotagliflozin on adipose distribution in non-diabetic patients - marketscreener.com

Dec 05, 2025

Dec 05, 2025

Clinical Data on Effect of Sotagliflozin on Adipose Distribution in Non-Diabetic Patients will be Presented at the 2025 Cardio Vascular Clinical Trialists Forum - The Manila Times

Dec 05, 2025

Dec 05, 2025

Clinical Data On Effect Of Sotagliflozin On Adipose Distribution In Non-Diabetic Patients - TradingView

Dec 05, 2025

Dec 05, 2025

Lexicon Pharmaceuticals to Present Clinical Data on Sotagliflozin at CVCT 2025 Conference - Quiver Quantitative

Dec 05, 2025

Dec 05, 2025

Lexicon Pharmaceuticals, Inc. (LXRX) Makes Progress in Product Pipeline Development - MSN

Dec 05, 2025

Dec 05, 2025

Is Lexicon Pharmaceuticals Inc. stock attractive for ETFs2025 Key Highlights & Daily Profit Maximizing Trade Tips - Newser

Dec 05, 2025

Dec 04, 2025

Year in Review: Local co. striking deal worth up to $1B with Ozempic maker was a Deal of the Week - The Business Journals

Dec 04, 2025

Dec 03, 2025

Carcinoid Syndrome Market to Expand Significantly by 2034, - openPR.com

Dec 03, 2025

Dec 03, 2025

Lexicon Pharmaceuticals Has Multiple Paths To Upside, But Formidable Hurdles As Well - Seeking Alpha

Dec 03, 2025

Dec 03, 2025

Piper Sandler Healthcare Conference - marketscreener.com

Dec 03, 2025

Dec 03, 2025

Lexicon Pharmaceuticals (LXRX) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 03, 2025

Dec 02, 2025

Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock Crosses Above Two Hundred Day Moving AverageWhat's Next? - MarketBeat

Dec 02, 2025

Nov 29, 2025

Will Lexicon Pharmaceuticals Inc. stock deliver long term returns2025 Market Overview & Fast Entry High Yield Stock Tips - moha.gov.vn

Nov 29, 2025

Nov 25, 2025

Lexicon Pharmaceuticals to Participate in Two Upcoming December Investor Conferences - The Manila Times

Nov 25, 2025

Nov 25, 2025

Lexicon Pharma (Nasdaq: LXRX) in Piper Sandler 37th and Evercore 8th investor events - Stock Titan

Nov 25, 2025

Nov 25, 2025

Would You Still Hold Lexicon Pharmaceuticals Stock If It Fell 30%? - Trefis

Nov 25, 2025

Nov 23, 2025

10 Fastest Growing Penny Stocks to Buy Now - Insider Monkey

Nov 23, 2025

Nov 21, 2025

Why Lexicon Pharmaceuticals Inc. stock is considered a top pick2025 Stock Rankings & Daily Market Momentum Tracking - newser.com

Nov 21, 2025

Nov 21, 2025

Can Lexicon Pharmaceuticals Inc. stock deliver consistent earnings growthWeekly Trend Recap & Reliable Intraday Trade Plans - newser.com

Nov 21, 2025

Nov 20, 2025

Will Lexicon Pharmaceuticals Inc. stock split attract more investorsBear Alert & Daily Price Action Insights - newser.com

Nov 20, 2025